Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIVERSITY trial of dabigatran versus standard anticoagulation for pediatric venous thromboembolism
MOH_2017-05-09_000402Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dabigatran in venous thromboembolism (VTE) (2 arms), sponsored by Boehringer Ingelheim. Started Jan 2014; status: completed.
02
Drugs
dabigatran
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on MOH_2017-05-09_000402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-05-09_000402.